Cargando…

RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY

INTRODUCTION: Astroblastoma is a rare, mostly supratentorial glial tumor, occurring predominantly in children and young adults. However, treatment strategies have not yet been established for this rare disease. CASE PRESENTATION: A 6-year-old male presented with headache and nausea. CT and MR imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimoto, Shota, Kawanishi, Yu, Fujita, Shohei, Yawata, Toshio, Ueba, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715129/
http://dx.doi.org/10.1093/neuonc/noaa222.789
_version_ 1783618882022408192
author Nishimoto, Shota
Kawanishi, Yu
Fujita, Shohei
Yawata, Toshio
Ueba, Tetsuya
author_facet Nishimoto, Shota
Kawanishi, Yu
Fujita, Shohei
Yawata, Toshio
Ueba, Tetsuya
author_sort Nishimoto, Shota
collection PubMed
description INTRODUCTION: Astroblastoma is a rare, mostly supratentorial glial tumor, occurring predominantly in children and young adults. However, treatment strategies have not yet been established for this rare disease. CASE PRESENTATION: A 6-year-old male presented with headache and nausea. CT and MR imaging revealed a left frontal mass lesion with slight edema and macrocalcifications. Gross tumor resection was performed. Histological examination found neoplastic cells with astroblastic characteristics, and a striking perivascular array of pseudorosettes. The final diagnosis was high-grade astroblastoma. MR imaging 13 months after surgery suggested local recurrence and enlargement was found 3 months later. Stereotactic radiotherapy (SRT) was performed. MR imaging after SRT showed enhanced cyst formation around the tumor bed, suggesting tumor recurrence. However, (11)C-methionine PET revealed radiation necrosis. The last follow-up MR imaging 15 months after SRT showed no further recurrence. CONCLUSION: Astroblastoma is rare, so no optimal management is known. SRT may be effective to treat recurrent astroblastomas. (11)C-methionine PET/CT is useful for the differentiation from radiation necrosis.
format Online
Article
Text
id pubmed-7715129
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77151292020-12-09 RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY Nishimoto, Shota Kawanishi, Yu Fujita, Shohei Yawata, Toshio Ueba, Tetsuya Neuro Oncol Radiation Oncology INTRODUCTION: Astroblastoma is a rare, mostly supratentorial glial tumor, occurring predominantly in children and young adults. However, treatment strategies have not yet been established for this rare disease. CASE PRESENTATION: A 6-year-old male presented with headache and nausea. CT and MR imaging revealed a left frontal mass lesion with slight edema and macrocalcifications. Gross tumor resection was performed. Histological examination found neoplastic cells with astroblastic characteristics, and a striking perivascular array of pseudorosettes. The final diagnosis was high-grade astroblastoma. MR imaging 13 months after surgery suggested local recurrence and enlargement was found 3 months later. Stereotactic radiotherapy (SRT) was performed. MR imaging after SRT showed enhanced cyst formation around the tumor bed, suggesting tumor recurrence. However, (11)C-methionine PET revealed radiation necrosis. The last follow-up MR imaging 15 months after SRT showed no further recurrence. CONCLUSION: Astroblastoma is rare, so no optimal management is known. SRT may be effective to treat recurrent astroblastomas. (11)C-methionine PET/CT is useful for the differentiation from radiation necrosis. Oxford University Press 2020-12-04 /pmc/articles/PMC7715129/ http://dx.doi.org/10.1093/neuonc/noaa222.789 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Radiation Oncology
Nishimoto, Shota
Kawanishi, Yu
Fujita, Shohei
Yawata, Toshio
Ueba, Tetsuya
RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
title RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
title_full RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
title_fullStr RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
title_full_unstemmed RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
title_short RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
title_sort ronc-20. recurrent high-grade astroblastoma treated with stereotactic radiotherapy
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715129/
http://dx.doi.org/10.1093/neuonc/noaa222.789
work_keys_str_mv AT nishimotoshota ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy
AT kawanishiyu ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy
AT fujitashohei ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy
AT yawatatoshio ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy
AT uebatetsuya ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy